Literature DB >> 32386831

Oesophageal pressure and respiratory muscle ultrasonographic measurements indicate inspiratory effort during pressure support ventilation.

Michele Umbrello1, Paolo Formenti1, Andrea C Lusardi2, Mariateresa Guanziroli2, Alessio Caccioppola2, Silvia Coppola1, Davide Chiumello3.   

Abstract

BACKGROUND: Bedside measures of patient effort are essential to properly titrate the level of pressure support ventilation. We investigated whether the tidal swing in oesophageal (ΔPes) and transdiaphragmatic pressure (ΔPdi), and ultrasonographic changes in diaphragm (TFdi) and parasternal intercostal (TFic) thickening are reliable estimates of respiratory effort. The effect of diaphragm dysfunction was also considered.
METHODS: Twenty-one critically ill patients were enrolled: age 73 (14) yr, BMI 27 (7) kg m-2, and Pao2/Fio2 33.3 (9.2) kPa. A three-level pressure support trial was performed: baseline, 25% (PS-medium), and 50% reduction (PS-low). We recorded the oesophageal and transdiaphragmatic pressure-time products (PTPs), work of breathing (WOB), and diaphragm and intercostal ultrasonography. Diaphragm dysfunction was defined by the Gilbert index.
RESULTS: Pressure support was 9.0 (1.6) cm H2O at baseline, 6.7 (1.3) (PS-medium), and 4.4 (1.0) (PS-low). ΔPes was significantly associated with the oesophageal PTP (R2=0.868; P<0.001) and the WOB (R2=0.683; P<0.001). ΔPdi was significantly associated with the transdiaphragmatic PTP (R2=0.820; P<0.001). TFdi was only weakly correlated with the oesophageal PTP (R2=0.326; P<0.001), and the correlation improved after excluding patients with diaphragm dysfunction (R2=0.887; P<0.001). TFdi was higher and TFic lower in patients without diaphragm dysfunction: 33.6 (18.2)% vs 13.2 (9.2)% and 2.1 (1.7)% vs 12.7 (9.1)%; P<0.0001.
CONCLUSIONS: ΔPes and ΔPdi are adequate estimates of inspiratory effort. Diaphragm ultrasonography is a reliable indicator of inspiratory effort in the absence of diaphragm dysfunction. Additional measurement of parasternal intercostal thickening may discriminate a low inspiratory effort or a high effort in the presence of a dysfunctional diaphragm.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  critical care; diaphragm; intercostal muscle; oesophageal pressure; pressure support ventilation; ultrasonography; work of breathing

Year:  2020        PMID: 32386831     DOI: 10.1016/j.bja.2020.02.026

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Diaphragmatic ultrasound and esophageal pressure in COVID-19 pneumonia during helmet CPAP.

Authors:  Irene Steinberg; Elena Chiodaroli; Simone Gattarello; Simone Cappio Borlino; Davide Chiumello
Journal:  Intensive Care Med       Date:  2022-06-21       Impact factor: 41.787

2.  Early rehabilitation relieves diaphragm dysfunction induced by prolonged mechanical ventilation: a randomised control study.

Authors:  Zehua Dong; Ying Liu; Yubiao Gai; Pingping Meng; Hui Lin; Yuxiao Zhao; Jinyan Xing
Journal:  BMC Pulm Med       Date:  2021-03-29       Impact factor: 3.317

3.  Central venous pressure swing outperforms diaphragm ultrasound as a measure of inspiratory effort during pressure support ventilation in COVID-19 patients.

Authors:  Sergio Lassola; Sara Miori; Andrea Sanna; Alberto Cucino; Sandra Magnoni; Michele Umbrello
Journal:  J Clin Monit Comput       Date:  2021-02-26       Impact factor: 2.502

Review 4.  Ultrasound and non-ultrasound imaging techniques in the assessment of diaphragmatic dysfunction.

Authors:  Franco A Laghi; Marina Saad; Hameeda Shaikh
Journal:  BMC Pulm Med       Date:  2021-03-15       Impact factor: 3.317

5.  High parasternal intercostal muscle thickening prior to intubation in COVID-19 infection.

Authors:  Abdallah Fayssoil; Robert Carlier; Nicolas Mansencal; Frédéric Lofaso; Djillali Annane
Journal:  Radiol Case Rep       Date:  2022-01-06

6.  Respiratory and peripheral muscular ultrasound characteristics in ICU COVID 19 ARDS patients.

Authors:  P Formenti; M Umbrello; V Castagna; S Cenci; F Bichi; T Pozzi; M Bonifazi; S Coppola; D Chiumello
Journal:  J Crit Care       Date:  2021-09-29       Impact factor: 3.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.